You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 3, July 19, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Special Communications
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Looking Through a Keyhole at the Tobacco Industry

The Brown and Williamson Documents

Stanton A. Glantz, PhD; Deborah E. Barnes; Lisa Bero, PhD; Peter Hanauer, LLB; John Slade, MD

JAMA. 1995;274(3):219-224.


Abstract

Objective.
—To introduce a series of papers discussing previously undocumented tobacco industry activities regarding strategies to avoid products liability litigation, understand nicotine addiction, and manipulate both internal and external scientific research on the effects of both active and passive smoking.

Data Sources.
—Documents from Brown and Williamson Tobacco Corporation (B&W), the British American Tobacco Company (BAT), and other tobacco interests provided by an anonymous source, obtained from Congress, and received from the private papers of a former BAT officer.

Study Selection.
—All available materials, including confidential reports regarding research and internal memoranda exchanged between tobacco industry lawyers.

Conclusions.
—These documents provide our first look at the inner workings of the tobacco industry during the crucial period in which the scientific case that smoking is addictive and kills smokers solidified. The documents show a sophisticated legal and public relations strategy to avoid liability for the diseases induced by tobacco use. The documents show that lawyers steered scientists away from particular research avenues, which is inconsistent with the company's purported disbelief in the causation and addiction claims; if the company had been genuinely unconvinced by the causation and addiction hypotheses, then it should have had no concern that new research would provide ammunition for the enemy. Quite the contrary, the documents show that B&W and BAT recognized more than 30 years ago that nicotine is addictive and that tobacco smoke is "biologically active" (eg, carcinogenic).

(JAMA. 1995;274:219-224)



Author Affiliations

From the Institute for Health Policy Studies, Department of Medicine and Division of Clinical Pharmacy, University of California, San Francisco (Drs Glantz and Bero, Ms Barnes, and Mr Hanauer), and the Department of Medicine, St Peter's Medical Center, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick (Dr Slade).


Footnotes

Reprint requests to Division of Cardiology, Box 0124, University of California, San Francisco, CA 94143-0124 (Dr Glantz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Open Doorway to Truth: Legacy of the Minnesota Tobacco Trial
Hurt et al.
Mayo Clin Proc. 2009;84:446-456.
ABSTRACT | FULL TEXT  

Waking a Sleeping Giant: The Tobacco Industry's Response to the Polonium-210 Issue
Muggli et al.
AJPH 2008;98:1643-1650.
ABSTRACT | FULL TEXT  

Evarts A. Graham and the First Pneumonectomy for Lung Cancer
Horn and Johnson
JCO 2008;26:3268-3275.
FULL TEXT  

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Vandenbroucke et al.
ANN INTERN MED 2007;147:W-163-W-194.
ABSTRACT | FULL TEXT  

The Cigarette Controversy
Cummings et al.
Cancer Epidemiol. Biomarkers Prev. 2007;16:1070-1076.
ABSTRACT | FULL TEXT  

Every document and picture tells a story: using internal corporate document reviews, semiotics, and content analysis to assess tobacco advertising
Anderson et al.
Tobacco Control 2006;15:254-261.
ABSTRACT | FULL TEXT  

Tobacco document research reporting
Carter
Tobacco Control 2005;14:368-376.
ABSTRACT | FULL TEXT  

The most important and influential papers in tobacco control: results of an online poll
Chapman
Tobacco Control 2005;14:e1-e1.
FULL TEXT  

"We are anxious to remain anonymous": the use of third party scientific and medical consultants by the Australian tobacco industry, 1969 to 1979
Chapman
Tobacco Control 2003;12:iii31-37.
ABSTRACT | FULL TEXT  

Evaluation of the American Stop Smoking Intervention Study (ASSIST): A Report of Outcomes
Stillman et al.
JNCI J Natl Cancer Inst 2003;95:1681-1691.
ABSTRACT | FULL TEXT  

Development of a model of the tobacco industry's interference with tobacco control programmes
Trochim et al.
Tobacco Control 2003;12:140-147.
ABSTRACT | FULL TEXT  

Tobacco Control: An Update to Influence Policy-Making Decisions
Heath et al.
Policy Politics Nursing Practice 2003;4:36-44.
ABSTRACT  

Exposing Mr Butts' tricks of the trade
Cummings and Pollay
Tobacco Control 2002;11:i1-4.
FULL TEXT  

Tobacco Dependence Curricula in Acute Care Nurse Practitioner Education
Heath et al.
Am J Crit Care 2002;11:27-33.
ABSTRACT | FULL TEXT  

Universities and tobacco money
Cohen
BMJ 2001;323:1-2.
FULL TEXT  

A Future Without Tobacco: A Call for Papers
Cole
JAMA 1999;282:1284-1284.
FULL TEXT  

Institutional addiction to tobacco
COHEN et al.
Tobacco Control 1999;8:70-74.
FULL TEXT  

The Cigarette Papers
Daynard
Journal of Health Politics, Policy and Law 1999;24:1400-1403.
 

Prying Open the Door to the Tobacco Industry's Secrets About Nicotine: The Minnesota Tobacco Trial
Hurt and Robertson
JAMA 1998;280:1173-1181.
ABSTRACT | FULL TEXT  

"The Tobacco Products Research Trust 1982-1996"
SWANN et al.
Tobacco Control 1998;7:193-193.
FULL TEXT  

Substance Misuse: What Have We Learned?
Stanton
Global Health Promotion 1997;4:37-40.
 

Tobacco Litigation: Issues for Public Health and Public Policy
Glantz et al.
JAMA 1997;277:751-753.
ABSTRACT  

FDA Regulation of Tobacco Advertising and Youth Smoking: Historical, Social, and Constitutional Perspectives
Gostin et al.
JAMA 1997;277:410-418.
ABSTRACT  

Tobacco Industry Strategies to Oppose Federal Regulation
Arno et al.
JAMA 1996;275:1258-1262.
ABSTRACT  

The Ledger of Tobacco Control: Is the Cup Half Empty or Half Full?
Davis
JAMA 1996;275:1281-1284.
ABSTRACT  

AMA ACCUSES TOBACCO SELLERS OF DUPING THE PUBLIC
JWatch General 1995;1995:6-6.
FULL TEXT  

Nicotine and Addiction: The Brown and Williamson Documents
Slade et al.
JAMA 1995;274:225-233.
ABSTRACT  

Lawyer Control of Internal Scientific Research to Protect Against Products Liability Lawsuits: The Brown and Williamson Documents
Hanauer et al.
JAMA 1995;274:234-240.
ABSTRACT  

Lawyer Control of the Tobacco Industry's External Research Program: The Brown and Williamson Documents
Bero et al.
JAMA 1995;274:241-247.
ABSTRACT  

Environmental Tobacco Smoke: The Brown and Williamson Documents
Barnes et al.
JAMA 1995;274:248-253.
ABSTRACT  

The Brown and Williamson Documents: Where Do We Go From Here?
Todd et al.
JAMA 1995;274:256-258.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.